Fetal echocardiographic assessment of endocardial fibroelastosis in maternal anti-SSA antibody-associated complete heart block

Circulation Journal

Volumn 75, Issue 5, 2011, Pages 1215-1221

  Aoki, Hisaaki ^a   Inamura, Noboru ^a   Kawazu, Yukiko ^a   Nakayama, Masahiro ^a   Kayatani, Futoshi ^a  

^a RESEARCH INSTITUTE FOR MATERNAL AND CHILD HEALTH   (Japan)

Author keywords

Anti SSA antibody; Congenital complete heart block; Endocardial fibroelastosis; Fetal echocardiography

Indexed keywords

RO ANTIBODY;

ARTERIAL WALL THICKNESS; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; COMPLETE HEART BLOCK; CONTROLLED STUDY; DISEASE ASSOCIATION; ECHOCARDIOGRAPHY; ENDOCARDIAL FIBROELASTOSIS; ENDOCARDIUM; FEMALE; FETUS; FETUS ECHOGRAPHY; HEART VENTRICLE WALL; HUMAN; OUTCOME ASSESSMENT; SURVIVAL RATE;

ANTIBODIES, ANTINUCLEAR; AUTOANTIBODIES; ECHOCARDIOGRAPHY; ENDOCARDIAL FIBROELASTOSIS; ENDOCARDIUM; FEMALE; FETUS; HEART BLOCK; HEART VENTRICLES; HUMANS; MATERNAL-FETAL EXCHANGE; MOTHERS; PREGNANCY; PROGNOSIS; TREATMENT OUTCOME; ULTRASONOGRAPHY, PRENATAL;

EID: 79955686233     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-10-1032     Document Type: Article

References (18)

1. Reed BR, Lee LA, Harmon C, Wolfe R, Wiggins J, Peebles C, et al. Autoantibodies to ss-a/ro in infants with congenital heart block. J Pediatr 1983; 103: 889-891.
2. Scott JS, Maddison PJ, Taylor PV, Esscher E, Scott O, Skinner RP. Connective-tissue disease, antibodies to ribonucleoprotein, and congenital heart block. N Engl J Med 1983; 309: 209-212.
3. Taylor-Albert E, Reichlin M, Toews WH, Overholt ED, Lee LA. Delayed dilated cardiomyopathy as a manifestation of neonatal lupus: Case reports, autoantibody analysis, and management. Pediatrics 1997; 99: 733-735.
4. Nield LE, Silverman ED, Taylor GP, Smallhorn JF, Mullen JB, Silverman NH, et al. Maternal anti-ro and anti-la antibody-associated endocardial fibroelastosis. Circulation 2002; 105: 843-848.
5. Jaeggi ET, Hamilton RM, Silverman ED, Zamora SA, Hornberger LK. Outcome of children with fetal, neonatal or childhood diagnosis of isolated congenital atrioventricular block: A single institution's experience of 30 years. J Am Coll Cardiol 2002; 39: 130-137.
6. Sahn DJ, Lange LW, Allen HD, Goldberg SJ, Anderson C, Giles H, et al. Quantitative real-time cross-sectional echocardiography in the developing normal humam fetus and newborn. Circulation 1980; 62: 588-597.
7. Julkunen H, Kaaja R, Wallgren E, Teramo K. Isolated congenital heart block: Fetal and infant outcome and familial incidence of heart block. Obstet Gynecol 1993; 82: 11-16.
8. Buyon JP, Hiebert R, Copel J, Craft J, Friedman D, Katholi M, et al. Autoimmune-associated congenital heart block: Demographics, mortality, morbidity and recurrence rates obtained from a national neonatal lupus registry. J Am Coll Cardiol 1998; 31: 1658-1666.
9. Nield LE, Silverman ED, Smallhorn JF, Taylor GP, Mullen JB, Benson LN, et al. Endocardial fibroelastosis associated with maternal anti-ro and anti-la antibodies in the absence of atrioventricular block. J Am Coll Cardiol 2002; 40: 796-802.
10. Ciurzynski M, Lichodziejewska B, Tomaszewski A, Piotrowska-Kownacka D, Kownacki L, Rymarczyk Z, et al. Biventricular noncompaction associated with left ventricular systolic and diastolic dysfunction and severe pulmonary hypertension in a young man. Circ J 2009; 73: 2163-2165.
11. Jaeggi E, Laskin C, Hamilton R, Kingdom J, Silverman E. The importance of the level of maternal anti-ro/ssa antibodies as a prognostic marker of the development of cardiac neonatal lupus erythematosus a prospective study of 186 antibody-exposed fetuses and infants. J Am Coll Cardiol 2010; 55: 2778-2784.
12. Viana VS, Garcia S, Nascimento JH, Elkon KB, Brot N, Campos de Carvalho AC, et al. Induction of in vitro heart block is not restricted to affinity purified anti-52 kda ro/ssa antibody from mothers of children with neonatal lupus. Lupus 1998; 7: 141-147.
13. Salomonsson S, Dorner T, Theander E, Bremme K, Larsson P, Wahren-Herlenius M. A serologic marker for fetal risk of congenital heart block. Arthritis Rheum 2002; 46: 1233-1241.
14. Strandberg L, Winqvist O, Sonesson SE, Mohseni S, Salomonsson S, Bremme K, et al. Antibodies to amino acid 200-239 (p200) of ro52 as serological markers for the risk of developing congenital heart block. Clin Exp Immunol 2008; 154: 30-37.
15. Lee LA, Coulter S, Erner S, Chu H. Cardiac immunoglobulin deposition in congenital heart block associated with maternal anti-ro auto antibodies. Am J Med 1987; 83: 793-796.
16. Iida M, Inamura N, Takeuchi M. Newborn infant with maternal anti-ssa antibody-induced complete heart block accompanying cardiomyopathy. Circ J 2006; 70: 147-149.
17. Wahren-Herlenius M, Sonesson SE. Specificity and effector mechanisms of autoantibodies in congenital heart block. Curr Opin Immunol 2006; 18: 690-696.
18. Takemoto Y, Hasebe H, Osaka T, Yokoyama E, Kushiyama Y, Suzuki T, et al. Right ventricular septal pacing preserves long-term left ventricular function via minimizing pacing-induced left ventricular dyssynchrony in patients with normal baseline qrs duration. Circ J 2009; 73: 1829-1835.